Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhen-Qi-Jie-Du Granules in Palliative Care for Advanced Colorectal Cancer
NCT07854405Not yet recruiting
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Sep 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Randomised, open-label trial of Zhen-Qi-Jie-Du Granules in colorectal cancer (CRC) (9 arms), sponsored by Jiangsu Famous Medical Technology. Primary endpoint: Progression-Free Survival at 1 year. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Zhen-Qi-Jie-Du Granules
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07854405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07854405.